240 related articles for article (PubMed ID: 27784533)
21. [Results of different postoperative adjuvant therapies for stage Ib-IIa cervical carcinoma with risk factors].
Wen HW; Huang WP; Liu TY; Ma K; Tao X; Zhu LR; Liao QP
Zhonghua Fu Chan Ke Za Zhi; 2013 Dec; 48(12):920-4. PubMed ID: 24495686
[TBL] [Abstract][Full Text] [Related]
22. Influence of conformal radiotherapy technique on survival after chemoradiotherapy for patients with stage III non-small cell lung cancer in the National Cancer Data Base.
Sher DJ; Koshy M; Liptay MJ; Fidler MJ
Cancer; 2014 Jul; 120(13):2060-8. PubMed ID: 24692108
[TBL] [Abstract][Full Text] [Related]
23. Management and outcomes of clinical stage IIA/B seminoma: Results from the National Cancer Data Base 1998-2012.
Paly JJ; Lin CC; Gray PJ; Hallemeier CL; Beard C; Sineshaw H; Jemal A; Efstathiou JA
Pract Radiat Oncol; 2016; 6(6):e249-e258. PubMed ID: 27345128
[TBL] [Abstract][Full Text] [Related]
24. Adjuvant Radiation Therapy and Chemotherapy in Merkel Cell Carcinoma: Survival Analyses of 6908 Cases From the National Cancer Data Base.
Bhatia S; Storer BE; Iyer JG; Moshiri A; Parvathaneni U; Byrd D; Sober AJ; Sondak VK; Gershenwald JE; Nghiem P
J Natl Cancer Inst; 2016 Sep; 108(9):. PubMed ID: 27245173
[TBL] [Abstract][Full Text] [Related]
25. Efficacy of neoadjuvant chemotherapy in patients with FIGO stage IB1 to IIA cervical cancer: an international collaborative meta-analysis.
Kim HS; Sardi JE; Katsumata N; Ryu HS; Nam JH; Chung HH; Park NH; Song YS; Behtash N; Kamura T; Cai HB; Kim JW
Eur J Surg Oncol; 2013 Feb; 39(2):115-24. PubMed ID: 23084091
[TBL] [Abstract][Full Text] [Related]
26. Propensity Score Analysis of Radical Hysterectomy Versus Definitive Chemoradiation for FIGO Stage IIB Cervical Cancer.
Tomita N; Mizuno M; Makita C; Kondo S; Mori M; Sakata J; Tsubouchi H; Hirata K; Tachibana H; Kodaira T
Int J Gynecol Cancer; 2018 Oct; 28(8):1576-1583. PubMed ID: 30095702
[TBL] [Abstract][Full Text] [Related]
27. Prophylactic Extended-Field Irradiation for Patients With Cervical Cancer Treated With Concurrent Chemoradiotherapy: A Propensity-Score Matching Analysis.
Wang W; Liu X; Meng Q; Zhang F; Hu K
Int J Gynecol Cancer; 2018 Oct; 28(8):1584-1591. PubMed ID: 30153215
[TBL] [Abstract][Full Text] [Related]
28. Concurrent chemoradiation versus radiotherapy alone in cervical carcinoma: A randomized phase III trial.
Srivastava K; Paul S; Chufal KS; Shamsundar SD; Lal P; Pant MC; Bhatt M; Singh S; Gupta R
Asia Pac J Clin Oncol; 2013 Dec; 9(4):349-56. PubMed ID: 23710586
[TBL] [Abstract][Full Text] [Related]
29. Postoperative radiation rates in stage IIA1 cervical cancer: Is surgical treatment justified? An Israeli Gynecologic Oncology Group Study.
Yagur Y; Weitzner O; Gemer O; Lavie O; Beller U; Bruchim I; Vaknin Z; Levy T; Rabinovich A; Shachar IB; Meirovitz A; Arie AB; Derazne E; Raban O; Eitan R; Kadan Y; Fishman A; Helpman L
Gynecol Oncol; 2018 Aug; 150(2):288-292. PubMed ID: 29807695
[TBL] [Abstract][Full Text] [Related]
30. A comparison of stages IB1 and IB2 cervical cancers treated with radical hysterectomy. Is size the real difference?
Rutledge TL; Kamelle SA; Tillmanns TD; Gould NS; Wright JD; Cohn DE; Herzog TJ; Rader JS; Gold MA; Johnson GA; Walker JL; Mannel RS; McMeekin DS
Gynecol Oncol; 2004 Oct; 95(1):70-6. PubMed ID: 15385112
[TBL] [Abstract][Full Text] [Related]
31. Adjuvant radiation therapy is associated with improved overall survival in high-intermediate risk stage I endometrial cancer: A national cancer data base analysis.
Gupta V; McGunigal M; Prasad-Hayes M; Kalir T; Liu J
Gynecol Oncol; 2017 Jan; 144(1):119-124. PubMed ID: 27793358
[TBL] [Abstract][Full Text] [Related]
32. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer.
Rose PG; Bundy BN; Watkins EB; Thigpen JT; Deppe G; Maiman MA; Clarke-Pearson DL; Insalaco S
N Engl J Med; 1999 Apr; 340(15):1144-53. PubMed ID: 10202165
[TBL] [Abstract][Full Text] [Related]
33. A retrospective review of 15 years of radical radiotherapy with or without concurrent cisplatin and/or 5-fluorouracil for the treatment of locally advanced cervical cancer.
Borowsky ME; Elliott KS; Pezzullo JC; Santoso P; Choi W; Choi K; Abulafia O
Bull Cancer; 2005 Feb; 92(2):E19-24. PubMed ID: 15749639
[TBL] [Abstract][Full Text] [Related]
34. Patterns of adjuvant radiation usage and survival outcomes for stage I endometrial carcinoma in a large hospital-based cohort.
Wong AT; Rineer J; Schwartz D; Weiner J; Safdieh J; Choi K; Schreiber D
Gynecol Oncol; 2017 Jan; 144(1):113-118. PubMed ID: 27823769
[TBL] [Abstract][Full Text] [Related]
35. Chemoradiation with and without adjuvant extrafascial hysterectomy for IB2 cervical carcinoma.
Darus CJ; Callahan MB; Nguyen QN; Pastore LM; Schneider BF; Rice LW; Jazaeri AA
Int J Gynecol Cancer; 2008; 18(4):730-5. PubMed ID: 17949426
[TBL] [Abstract][Full Text] [Related]
36. Chemotherapy versus chemoradiotherapy for FIGO stages IB1 and IIA1 cervical squamous cancer patients with lymphovascular space invasion: a retrospective study.
Zhang H; Yu R; Zhang L; Wang R; Xiao L
BMC Cancer; 2022 Feb; 22(1):202. PubMed ID: 35193525
[TBL] [Abstract][Full Text] [Related]
37. Oncologic outcome of fertility-sparing radical trachelectomy versus radical hysterectomy for stage IB1 cervical carcinoma.
Diaz JP; Sonoda Y; Leitao MM; Zivanovic O; Brown CL; Chi DS; Barakat RR; Abu-Rustum NR
Gynecol Oncol; 2008 Nov; 111(2):255-60. PubMed ID: 18755500
[TBL] [Abstract][Full Text] [Related]
38. Chemoradiation in locally advanced cervical carcinoma: an analysis of cisplatin dosing and other clinical prognostic factors.
Nugent EK; Case AS; Hoff JT; Zighelboim I; DeWitt LL; Trinkhaus K; Mutch DG; Thaker PH; Massad LS; Rader JS
Gynecol Oncol; 2010 Mar; 116(3):438-41. PubMed ID: 19896180
[TBL] [Abstract][Full Text] [Related]
39. Laparoscopic versus open radical hysterectomy for stage IB2-IIB cervical cancer in the setting of neoadjuvant chemotherapy: a multi-institutional cohort study.
Ghezzi F; Cromi A; Ditto A; Vizza E; Malzoni M; Raspagliesi F; Uccella S; Corrado G; Cosentino F; Gotsch F; Martinelli F; Franchi M
Ann Surg Oncol; 2013 Jun; 20(6):2007-15. PubMed ID: 23224830
[TBL] [Abstract][Full Text] [Related]
40. Implications of Lymph Node Staging on Selection of Adjuvant Therapy for Gastric Cancer in the United States: A Propensity Score-matched Analysis.
Datta J; McMillan MT; Ecker BL; Karakousis GC; Mamtani R; Plastaras JP; Giantonio BJ; Drebin JA; Dempsey DT; Fraker DL; Roses RE
Ann Surg; 2016 Feb; 263(2):298-305. PubMed ID: 26135687
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
